These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1959449)

  • 1. Expanded transition state analogues.
    Blackburn GM; Kingsbury G; Jayaweera S; Burton DR
    Ciba Found Symp; 1991; 159():211-22; discussion 222-6. PubMed ID: 1959449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarities of hydrolytic antibodies revealed by their X-ray structures: a review.
    Charbonnier JB; Gigant B; Golinelli-Pimpaneau B; Knossow M
    Biochimie; 1997 Nov; 79(11):653-60. PubMed ID: 9479447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental determination of the absolute enantioselectivity of an antibody-catalyzed Diels-Alder reaction and theoretical explorations of the origins of stereoselectivity.
    Cannizzaro CE; Ashley JA; Janda KD; Houk KN
    J Am Chem Soc; 2003 Mar; 125(9):2489-506. PubMed ID: 12603137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of the exo and endo pathways of the Diels-Alder reaction by antibody catalysis.
    Gouverneur VE; Houk KN; de Pascual-Teresa B; Beno B; Janda KD; Lerner RA
    Science; 1993 Oct; 262(5131):204-8. PubMed ID: 8211138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transition state docking: a probe for noncovalent catalysis in biological systems. Application to antibody-catalyzed ester hydrolysis.
    Tantillo DJ; Houk KN
    J Comput Chem; 2002 Jan; 23(1):84-95. PubMed ID: 11913392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of the hapten for the induction of antibodies catalyzing aldol reaction.
    Teraishi K; Saito M; Fujii I; Nakamura H
    J Mol Graph; 1994 Dec; 12(4):282-5, 292. PubMed ID: 7696219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.
    Wenthur CJ; Cai X; Ellis BA; Janda KD
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3666-3668. PubMed ID: 28709828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The generation of antibody combining sites containing catalytic residues.
    Shokat KM; Schultz PG
    Ciba Found Symp; 1991; 159():118-28; discussion 128-34. PubMed ID: 1959444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of biomimetic catalysts by molecular imprinting in synthetic polymers: the role of transition state stabilization.
    Wulff G; Liu J
    Acc Chem Res; 2012 Feb; 45(2):239-47. PubMed ID: 21967389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An antibody exo Diels-Alderase inhibitor complex at 1.95 angstrom resolution.
    Heine A; Stura EA; Yli-Kauhaluoma JT; Gao C; Deng Q; Beno BR; Houk KN; Janda KD; Wilson IA
    Science; 1998 Mar; 279(5358):1934-40. PubMed ID: 9506943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological optimization of a generic hydrophobic pocket for high affinity hapten binding and Diels-Alder activity.
    Piatesi A; Hilvert D
    Chembiochem; 2004 Apr; 5(4):460-6. PubMed ID: 15185369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Origins and predictions of stereoselective antibody catalysis: theoretical analysis of Diels-Alder catalysis by 39A11 and its germ-line antibody.
    Zhang X; Deng Q; Yoo SH; Houk KN
    J Org Chem; 2002 Dec; 67(25):9043-53. PubMed ID: 12467427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient and selective p-nitrophenyl-ester-hydrolyzing antibodies elicited by a p-nitrobenzyl phosphonate hapten.
    Tawfik DS; Lindner AB; Chap R; Eshhar Z; Green BS
    Eur J Biochem; 1997 Mar; 244(2):619-26. PubMed ID: 9119032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition-state stabilization as a measure of the efficiency of antibody catalysis.
    Stewart JD; Benkovic SJ
    Nature; 1995 Jun; 375(6530):388-91. PubMed ID: 7760931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytic antibodies: a new window on protein chemistry.
    Suckling CJ; Tedford CM; Proctor GR; Khalaf AI; Bence LM; Stimson WH
    Ciba Found Symp; 1991; 159():201-8; discussion 208-10. PubMed ID: 1959448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for antibody catalysis of a disfavored ring closure reaction.
    Gruber K; Zhou B; Houk KN; Lerner RA; Shevlin CG; Wilson IA
    Biochemistry; 1999 Jun; 38(22):7062-74. PubMed ID: 10353817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation of antibody acyl hydrolysis catalysis using a large set of related haptens.
    Odenbaugh AL; Helms ED; Iverson BL
    Bioorg Med Chem; 2000 Feb; 8(2):413-26. PubMed ID: 10722164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that the mechanism of antibody-catalysed hydrolysis of arylcarbamates can be determined by the structure of the immunogen used to elicit the catalytic antibody.
    Boucher G; Said B; Ostler EL; Resmini M; Brocklehurst K; Gallacher G
    Biochem J; 2007 Feb; 401(3):721-6. PubMed ID: 17020536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. At the crossroads of chemistry and immunology: catalytic antibodies.
    Lerner RA; Benkovic SJ; Schultz PG
    Science; 1991 May; 252(5006):659-67. PubMed ID: 2024118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First example of an antibody-catalyzed aza Diels-Alder reaction.
    Shi ZD; Yang BH; Wu YL; Pan YJ; Ji YY; Yeh M
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2321-4. PubMed ID: 12161125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.